NS-0200

AssetAlso called NS-0200-0.5, NS-0200-1.0

Stage
Phase 2
Modality
Not known
Target
Not known
2
Indications
207
Trials
1
Developer

Trial NCT07647003 is still running. Trial NCT07647003 started on Oct 15, 2026. clinicaltrials.gov

Indications

2

In the full profile

  • Target and mechanism1
  • Owner and partners1
  • Trials207
  • Evidence for its targets1
  • Competitors12
  • Signals4

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets